Department of Chemistry, Chemical Biology, and Biomedical Engineering, Stevens Institute of Technology, Castle Point on Hudson, Hoboken, NJ 07030, USA.
Semin Cancer Biol. 2012 Oct;22(5-6):471-83. doi: 10.1016/j.semcancer.2012.07.003. Epub 2012 Jul 31.
Wound healing and cancer metastasis share a common starting point, namely, a change in the phenotype of some cells from stationary to motile. The term, epithelial-to-mesenchymal transition (EMT) describes the changes in molecular biology and cellular physiology that allow a cell to transition from a sedentary cell to a motile cell, a process that is relevant not only for cancer and regeneration, but also for normal development of multicellular organisms. The present review compares the similarities and differences in cellular response at the molecular level as tumor cells enter EMT or as keratinocytes begin the process of re-epithelialization of a wound. Looking toward clinical interventions that might modulate these processes, the mechanisms and outcomes of current and potential therapies are reviewed for both anti-cancer and pro-wound healing treatments related to the pathways that are central to EMT. Taken together, the comparison of re-epithelialization and tumor EMT serves as a starting point for the development of therapies that can selectively modulate different forms of EMT.
伤口愈合和癌症转移有一个共同的起点,即某些细胞的表型从静止到运动的转变。术语上皮-间充质转化(EMT)描述了允许细胞从静止细胞向运动细胞转变的分子生物学和细胞生理学变化,这个过程不仅与癌症和再生有关,而且与多细胞生物的正常发育有关。本综述比较了肿瘤细胞进入 EMT 或角质细胞开始伤口再上皮化过程中分子水平上细胞反应的相似性和差异性。着眼于可能调节这些过程的临床干预,本文综述了与 EMT 中心途径相关的抗癌和促进伤口愈合治疗的当前和潜在治疗的机制和结果。总的来说,再上皮化和肿瘤 EMT 的比较为开发能够选择性调节不同形式 EMT 的治疗方法提供了一个起点。